Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31002578

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2019 Jun 1
First author
Walker JL

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Jun 1;37(16):1359-1364. doi: 10.1200/JCO.19.00500.
    note
    Source null
    related pmid
    31002579
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2019 Sep 1;37(25):2299. doi: 10.1200/JCO.19.01365.
    note
    Source null
    related pmid
    31461635
    relationship
    Erratum in
  3. citation
    J Clin Oncol. 2019 Nov 20;37(33):3168-3169. doi: 10.1200/JCO.19.01163.
    note
    Source null
    related pmid
    31553677
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2019 Nov 20;37(33):3170. doi: 10.1200/JCO.19.02091.
    note
    Source null
    related pmid
    31553678
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2019 Nov 20;37(33):3169-3170. doi: 10.1200/JCO.19.01179.
    note
    Source null
    related pmid
    31553679
    relationship
    Comment in

Authors and identifiers

  1. name
    Walker JL
    type
    Author
  2. name
    Brady MF
    type
    Author
  3. name
    Wenzel L
    type
    Author
  4. name
    Fleming GF
    type
    Author
  5. name
    Huang HQ
    type
    Author
  6. name
    DiSilvestro PA
    type
    Author
  7. name
    Fujiwara K
    type
    Author
  8. name
    Alberts DS
    type
    Author
  9. name
    Zheng W
    type
    Author
  10. name
    Tewari KS
    type
    Author
  11. name
    Cohn DE
    type
    Author
  12. name
    Powell MA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Walker JL
    type
    Author
  2. name
    Brady MF
    type
    Author
  3. name
    Wenzel L
    type
    Author
  4. name
    Fleming GF
    type
    Author
  5. name
    Huang HQ
    type
    Author
  6. name
    DiSilvestro PA
    type
    Author
  7. name
    Fujiwara K
    type
    Author
  8. name
    Alberts DS
    type
    Author
  9. name
    Zheng W
    type
    Author
  10. name
    Tewari KS
    type
    Author
  11. name
    Cohn DE
    type
    Author
  12. name
    Powell MA
    type
    Author
bibliography ids
  1. nci-bib-cd090fdb283b336e526ac993
book metadata
content sha256
b1a9115349ff00ad9bbd31583be0544b9314104eca0924d765e44205da0c89f3
document type
citation
dois
  1. 10.1200/JCO.18.01568
electronic publication date
display
2019 Apr 19
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31002578
immutable id
pubmed:31002578@b1a9115349ff00ad9bbd31583be0544b9314104eca0924d765e44205da0c89f3
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
16
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1380-1390
volume
37
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Jun 1;37(16):1359-1364. doi: 10.1200/JCO.19.00500.
    note
    Source null
    related pmid
    31002579
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2019 Sep 1;37(25):2299. doi: 10.1200/JCO.19.01365.
    note
    Source null
    related pmid
    31461635
    relationship
    Erratum in
  3. citation
    J Clin Oncol. 2019 Nov 20;37(33):3168-3169. doi: 10.1200/JCO.19.01163.
    note
    Source null
    related pmid
    31553677
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2019 Nov 20;37(33):3170. doi: 10.1200/JCO.19.02091.
    note
    Source null
    related pmid
    31553678
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2019 Nov 20;37(33):3169-3170. doi: 10.1200/JCO.19.01179.
    note
    Source null
    related pmid
    31553679
    relationship
    Comment in
outcomes validated
false
pmid
31002578
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
a611218f737236914909f861171ff5e15bb9ac3c679b407d2ba6c99d8422c71a
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2019 Jun 1
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31002578/
title
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Preserved source evidence · Not medical advice